Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$12,193,303
+$834,882 QoQ
Shares Held
33,672
+4.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#487
of 3,140 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bell Bank holds $61,862,123 across 10 Drug Manufacturers - General names. AMGN ranks #2 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
53,948 | $13,575,473 | |
| 2 | AMGN |
Amgen Inc
This page
|
33,672 | $12,193,303 | |
| 3 | PFE |
Pfizer Inc
|
484,403 | $11,664,423 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
78,616 | $9,932,345 | |
| 5 | GSK |
GSK plc
|
181,234 | $9,500,285 | |
| 6 | LLY |
ELI LILLY & Co
|
2,255 | $2,704,714 | |
| 7 | JNJ |
Johnson & Johnson
|
5,046 | $1,281,532 | |
| 8 | MRK |
Merck & Co., Inc.
|
3,672 | $471,852 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,193,303 | 33,672 | Shares | Defined | 2026-07-16 | |
| 2026-03-31 | $11,358,421 | 32,282 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $9,806,861 | 29,962 | Shares | Defined | 2026-01-14 | |
| 2025-09-30 | $8,625,442 | 30,565 | Shares | Defined | 2025-10-21 | |
| 2025-06-30 | $8,434,933 | 30,210 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $9,804,478 | 31,470 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $8,010,248 | 30,733 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $8,459,945 | 26,256 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $9,624,084 | 30,802 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $8,971,717 | 31,555 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $8,944,461 | 31,055 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $8,609,726 | 32,035 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $7,316,669 | 32,955 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $8,414,350 | 34,806 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $9,114,395 | 34,703 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $7,991,557 | 35,455 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $7,487,070 | 30,773 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $6,893,320 | 28,506 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $5,150,238 | 22,893 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,811,963 | 17,926 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $3,935,343 | 16,145 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $3,620,931 | 14,553 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $3,008,043 | 13,083 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,013,829 | 11,858 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $2,920,654 | 12,383 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||